How M.D. was paid
$2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Steven Nichtberger, M.D.President and Chief Executive Officer | $659,550 | $1,266,978 | $446,982 | $28,045 | $1,954,573 |
| Gwendolyn K. Binder, Ph.D.President, Science and Technology | $516,700 | $484,124 | $243,262 | $14,000 | $1,014,824 |
| David J. Chang, M.D., M.P.H.Chief Medical Officer | $516,700 | $429,009 | $276,435 | $14,000 | $959,709 |
What changed and why
- $2MSteven Nichtberger received total compensation of $1,954,573 in fiscal 2025, down significantly from $8,096,947 in fiscal 2024.
- Option awards included the grant date fair value and incremental fair value from a May 2025 repricing.
- 107%Company performance for the annual cash incentive plan was approved at 107% of target.
- The compensation committee retained Aon as its external compensation consultant.
- 50%Shareholders holding in excess of 50% of shares outstanding were engaged following the 2025 say-on-pay vote.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.